Noticias de SGMO_US

Noticias del mercado

Últimas noticias sobre SGMO_US — 150 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: SGMO_US ✕ 150 resultados
31/03/2026 SGMO_US — TipRanks
Sangamo Therapeutics Faces Rising Trade Policy Risks, Higher Costs and Global Growth Uncertainty
30/03/2026 SGMO_US — MSN
Sangamo targets summer 2026 for Fabry BLA submission while advancing neurology pipeline and partner talks
30/03/2026 SGMO_US — 10TV ES ← EN
Sangamo: resumen de las ganancias del cuarto trimestre
30/03/2026 SGMO_US — Stock Titan
Sangamo pushes Fabry gene therapy toward FDA as cash runway reaches Q3
30/03/2026 SGMO_US — Yahoo Finance
Sangamo Therapeutics Reports Recent Business Highlights And Fourth Quarter And Full Year 2025 Financial Results
30/03/2026 SGMO_US — MarketBeat
Sangamo Therapeutics Q4 Earnings Call Highlights
30/03/2026 SGMO_US — Investing.com
Earnings call transcript: Sangamo’s Q4 2025 earnings miss, stock fluctuates
30/03/2026 SGMO_US — MarketScreener ES ← EN
Sangamo Therapeutics, Inc. informa cargos por deterioro consolidados no auditados para el cuarto trimestre finalizado el 31 de diciembre de 2025
30/03/2026 SGMO_US — MarketBeat
Sangamo Therapeutics (NASDAQ:SGMO) Releases Quarterly Earnings Results, Misses Expectations By $0.12 EPS
30/03/2026 SGMO_US — MarketBeat
Sangamo Therapeutics Q4 2025 Earnings Call Transcript
30/03/2026 SGMO_US — TradingView
Sangamo Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
30/03/2026 SGMO_US — Yahoo Finance
Sangamo Therapeutics Q4 Earnings Call Highlights
30/03/2026 SGMO_US — GuruFocus
Sangamo (SGMO) Reports Robust Revenue Growth and Pipeline Progre
30/03/2026 SGMO_US — theheraldreview.com
Sangamo: Q4 Earnings Snapshot
30/03/2026 SGMO_US — Benzinga
Sangamo Therapeutics Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnin
30/03/2026 SGMO_US — GuruFocus
Q4 2025 Sangamo Therapeutics Inc Earnings Call Transcript
30/03/2026 SGMO_US — TradingView
SGMO: Fabry and neurology pipeline progress, new partnerships, and funding highlight 2025 results
29/03/2026 SGMO_US — MarketScreener
Sangamo Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt
22/03/2026 SGMO_US — Stock Titan
If You Invested $1,000 in Sangamo Therapeutics Inc (SGMO)
20/03/2026 SGMO_US — TradingView
Sangamo Therapeutics Inc expected to post a loss of 6 cents a share - Earnings Preview

Página 7 de 8

keyboard_arrow_up